High blood pressure medication recalled because of cancer-causing substance


A New Jersey-based pharmaceutical company has recalled medications to control high blood pressure and heart failure. 

Prinston Pharmaceuticals Inc., dba Solco Healthcare LLC announced the recall of Irbesartan and Irbesarten HCTZ, both used to treat high blood pressure, citing trace amounts of a carcinogen. 

The carcinogen, a substance linked to cancer, was found in an ingredient manufactured by Zhejiang Huahai Pharmaceuticals. 

The pharmaceutical company is recalling one lot of Irbesartan and seven lots of Irbesarten HCTZ because of the increased levels of N-nitrosodiethylamine, the company says is above the safe level. 

The manufacturer says patients should continue to take the medication until a pharmacist or doctor provides a replacement medication. Patients are asked to contact their doctor regarding alternative treatment. 

Medications affected can be identified with the product name, manufacturer and batch or lot numbers.

Products affected by the medication recall can be found here

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Remarkable Women

Trending Stories

Covid-19 County by County tracker
Download Our App

Don't Miss

More Don't Miss